ArcticDx Comes to US, Eyes FDA Approval for AMD Test

ArcticDx's macular degeneration prognostic test officially launched as an LDT in the US in September, and the firm is targeting FDA approval to help propel it globally.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories